Department of Health and Human Services July 28, 2020 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2020-16341
Type: Notice
Date: 2020-07-28
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project ``AHRQ Safety Program for Improving Surgical Care and Recovery.''
Center for Scientific Review; Notice of Closed Meeting
Document Number: 2020-16269
Type: Notice
Date: 2020-07-28
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Document Number: 2020-16261
Type: Notice
Date: 2020-07-28
Agency: Department of Health and Human Services, National Institutes of Health
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2020-16260
Type: Notice
Date: 2020-07-28
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled on Public Health Associate Program (PHAP) Alumni and Host Site Assessment. This project is designed to assess the quality and value of the Public Health Associate Programs. The collection of information will inform program improvements and future decision making.
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2020-16259
Type: Notice
Date: 2020-07-28
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled ``Pilot Implementation of the Violence Against Children and Youth Survey (VACS) in the United States.'' This study is designed to conduct a pilot implementation of the Violence Against Children and Youth Survey (VACS) in the United States, which CDC has conducted in 24 countries globally.
Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: 2020-16258
Type: Notice
Date: 2020-07-28
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
IDLH Value Profile for Bromine Trifluoride, Chlorine Trifluoride, and Ethylene Dibromide
Document Number: 2020-16254
Type: Notice
Date: 2020-07-28
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
NIOSH announces the availability of IDLH Value Profiles for Bromine Trifluoride, Chlorine Trifluoride, and Ethylene Dibromide.
New Animal Drugs; Withdrawal of Approval of Abbreviated New Animal Drug Application
Document Number: 2020-15761
Type: Rule
Date: 2020-07-28
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is withdrawing approval of an abbreviated new animal drug application (ANADA) at the sponsor's request because the product is no longer manufactured or marketed.
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor
Document Number: 2020-15760
Type: Rule
Date: 2020-07-28
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during January, February, and March 2020. FDA is informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable. The animal drug regulations are also being amended to make technical amendments to improve the accuracy of the regulations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.